Browse Pet Safety Reports
17,908 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 17,908 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 17,908 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Jul 18, 2024 | Horse | Quarter Horse | MSK | Hives (see also Skin); Falling; Sternoabdominal recumbency; Sedation prolonged | Recovered/Normal |
| Jul 17, 2024 | Horse | Tennessee Walking Horse | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jul 16, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jul 16, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jul 16, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jul 15, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jul 15, 2024 | Horse | Horse (unknown) | MSK | Hives (see also Skin); Underdose | Recovered/Normal |
| Jul 15, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jul 15, 2024 | Horse | Pony (unspecified) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jul 15, 2024 | Horse | Horse (unknown) | MSK | Partial anorexia | Recovered/Normal |
| Jul 13, 2024 | Horse | Horse (unknown) | MSK | Lethargy (see also Central nervous system depression in Neurological); Inject... | Recovered/Normal |
| Jul 12, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jul 12, 2024 | Horse | Unknown | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jul 10, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Ongoing |
| Jul 10, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jul 10, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Jul 10, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Jul 9, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Jul 9, 2024 | Horse | Hanovarian | MSK | Lymph node abscess | Outcome Unknown |
| Jul 9, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jul 9, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Ongoing |
| Jul 9, 2024 | Horse | Warmblood (unspecified) | MSK | Reluctant to move; Bone and joint disorder NOS; Tachycardia; Abnormal digital... | Outcome Unknown |
| Jul 8, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Jul 8, 2024 | Horse | Warmblood (unspecified) | MSK | Joint effusion; Cellulitis | Outcome Unknown |
| Jul 5, 2024 | Horse | Thoroughbred | MSK | Joint effusion; Lameness; Death by euthanasia | Euthanized |
| Jul 4, 2024 | Horse | Unknown | MSK | Elevated aspartate aminotransferase (AST); Elevated gamma-glutamyl transferas... | Outcome Unknown |
| Jul 3, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Jul 3, 2024 | Horse | Quarter Horse | MSK | Not eating | Recovered/Normal |
| Jul 3, 2024 | Horse | Unknown | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Jul 3, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jul 2, 2024 | Horse | Quarter Horse | MSK | Injection site swelling; Rolling; Hard stool; Gut sounds decreased | Outcome Unknown |
| Jul 1, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Jul 1, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Jul 1, 2024 | Horse | Horse (unknown) | MSK | High adrenocorticotropic (ACTH) hormone; Localised hair loss | Outcome Unknown |
| Jul 1, 2024 | Horse | Unknown | MSK | Oral swelling; Abnormal rectal palpation | Outcome Unknown |
| Jul 1, 2024 | Horse | Quarter Horse | MSK | Injection site swelling; Injection site warmth; Injection site pain; Fever; O... | Ongoing |
| Jul 1, 2024 | Horse | Quarter Horse | MSK | Hives (see also Skin) | Recovered/Normal |
| Jul 1, 2024 | Horse | Horse (unknown) | MSK | Food refusal; Lethargy (see also Central nervous system depression in Neurolo... | Outcome Unknown |
| Jul 1, 2024 | Horse | Welsh Cob | MSK | Death by euthanasia; Seizure NOS; Fracture; Falling; Elevated liver enzymes N... | Euthanized |
| Jul 1, 2024 | Horse | Tennessee Walking Horse | MSK | Anorexia; Diarrhoea; Hypoproteinaemia | Recovered/Normal |
| Jul 1, 2024 | Horse | Unknown | MSK | Lack of efficacy - NOS | Ongoing |
| Jun 30, 2024 | Horse | Warmblood (unspecified) | MSK | Injection site hair loss | Outcome Unknown |
| Jun 30, 2024 | Horse | Warmblood (unspecified) | MSK | Heavy sweating; Trembling; Collapse NOS (see also Cardio-vascular and Neurolo... | Recovered/Normal |
| Jun 30, 2024 | Horse | Horse (unknown) | MSK | Angioedema | Outcome Unknown |
| Jun 29, 2024 | Horse | Quarter Horse | MSK | Diarrhoea; Elevated renal parameters; Increased packed cell volume (PCV) | Recovered/Normal |
| Jun 29, 2024 | Horse | Quarter Horse | MSK | Diarrhoea; Elevated renal parameters; Increased packed cell volume (PCV); Inf... | Ongoing |
| Jun 28, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS; Intentional misuse | Outcome Unknown |
| Jun 28, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS; Intentional misuse | Recovered/Normal |
| Jun 27, 2024 | Horse | Quarter Horse | MSK | Injection site swelling; Muscle stiffness | Outcome Unknown |
| Jun 27, 2024 | Horse | Mustang | MSK | Sedation prolonged; Behavioural disorder NOS | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.